In a path-breaking move that will help bring HIV medicine to the masses, drug giant Gilead Sciences signed deals with three Indian firms, including Ranbaxy Laboratories to collaborate on providing low-cost generic versions of its …
Yesterday the US FDA approved Truvada, the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of infection and who may engage in sexual activity with HIV-infected partners.The …
Truvada, the first ever pill to beat HIV -- a breakthrough in the 30-year-old war against AIDS epidemic -- is under active consideration of the US Food and Drug Administration (FDA) for approval.
Currently used to treat HIV, …
